CERN - Cerner Corp. (NASDAQ) - Share Price and News

Overview

Cerner's health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people.

Basic Stats

The share price of Cerner Corp. as of June 7, 2022 is $94.92 / share.

The Factor Analysis chart (below right) shows a view of Cerner Corp. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.

For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.

Market Cap
EV
Shares Out.
Earnings Date
EPS (TTM)
Dividend Yield
Ex-Dividend Date

Borrow Rate
Short Shares Avail.
Short Interest
Short Float
Days to Cover

Risk Free Rate	4.22 %
Price Change (1 yr)
Volatility (1 yr)
Beta
Sharpe Ratio (1 yr)
Sortino Ratio (1 yr)

PE Ratio
Price/Book
Price/TBV
Book/Market
EBIT/EV
EBIT(3yr avg)/EV

ROA
ROE
ROIC
CROIC
OCROIC

Implied Volatility
Put/Call OI Ratio

Growth
Profitability
Quality Score
Value Score
Momentum Score
Stability (Low Vol) Score
Analyst Sentiment
Fund Sentiment
Insider Sentiment
Officer Sentiment
Dividend Score
QVM Score
Piotroski F-SCORE

Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.

Price Target

The average one-year price target for Cerner Corp. is $96.34. The forecasts range from a low of $88.88 to a high of $105.00. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.

Update Frequency: Monthly

Record Date	Projection Date	High	Low	Median	Average
2023-03-27	2024-03-27	105.00	88.88	96.90	96.34

Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Cerner Corp.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:

Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Date	Analyst	Prior	Latest Recommendation	Action
2022-04-11	Argus Research	Buy	Hold	Downgrade
2021-12-22	Keybanc	Overweight	Sector Weight	Downgrade
2021-12-21	SVB Leerink	Outperform	Market Perform	Downgrade
2021-12-21	RBC Capital	Outperform	Sector Perform	Downgrade
2021-12-21	Morgan Stanley		Equal-Weight	Maintains
2021-12-20	Morgan Stanley	Underweight	Equal-Weight	Upgrade
2021-11-17	Baird		Neutral	Initiate
2021-11-01	Barclays		Equal-Weight	Maintains
2021-08-31	Morgan Stanley		Underweight	Maintains
2021-08-02	SVB Leerink		Outperform	Maintains
2021-08-02	Canaccord Genuity		Buy	Maintains
2021-05-06	SVB Leerink		Outperform	Maintains
2021-02-16	Piper Sandler		Overweight	Maintains
2021-02-11	UBS	Buy	Neutral	Downgrade
2021-02-11	Morgan Stanley		Underweight	Maintains
2021-02-11	KeyBanc		Overweight	Maintains
2021-01-19	B of A Securities	Buy	Underperform	Downgrade
2020-10-29	Wells Fargo		Overweight	Maintains
2020-10-29	SVB Leerink		Outperform	Maintains
2020-10-29	Deutsche Bank		Buy	Maintains
2020-07-31	Morgan Stanley		Underweight	Maintains
2020-07-07	Stephens & Co.		Equal-Weight	Initiate
2020-05-13	Morgan Stanley		Underweight	Maintains
2020-05-01	SunTrust Robinson Humphrey	Buy	Hold	Downgrade
2020-04-29	UBS		Buy	Maintains
2020-04-29	Barclays		Equal-Weight	Maintains
2020-04-22	Jefferies	Hold	Buy	Upgrade
2020-03-30	Cowen & Co.	Market Perform	Outperform	Upgrade
2020-03-27	Morgan Stanley		Underweight	Maintains
2020-03-26	SunTrust Robinson Humphrey		Buy	Maintains
2020-03-11	UBS		Buy	Maintains
2020-03-11	SunTrust Robinson Humphrey		Buy	Maintains
2020-03-11	JP Morgan		Neutral	Maintains
2020-02-05	CFRA		Hold	Maintains
2020-02-05	Canaccord Genuity		Buy	Maintains
2020-02-05	Baird		Outperform	Maintains
2020-01-08	Wells Fargo		Overweight	Maintains
2019-12-16	SunTrust Robinson Humphrey		Buy	Maintains
2019-11-26	UBS		Buy	Initiate
2019-11-22	RBC Capital		Outperform	Initiate
2019-09-26	Deutsche Bank		Buy	Initiate
2019-08-23	Morgan Stanley		Underweight	Maintains
2019-08-23	Jefferies	Buy	Hold	Downgrade
2019-08-22	Argus Research	Hold	Buy	Upgrade
2019-08-22	Argus	Hold	Buy	Upgrade
2019-08-16	KeyBanc		Overweight	Maintains
2019-07-25	Canaccord Genuity		Buy	Maintains
2019-07-08	Cantor Fitzgerald		Overweight	Maintains
2019-05-24	Canaccord Genuity		Buy	Maintains
2019-05-21	Bank of America		Buy	Maintains
2019-04-10	SunTrust Robinson Humphrey	Hold	Buy	Upgrade
2019-04-10	Baird	Outperform	Outperform	Maintains
2019-02-28	Morgan Stanley	Equal-Weight	Underweight	Downgrade
2018-12-03	Morgan Stanley	Equal-Weight	Equal-Weight	Maintains
2018-10-29	Leerink Swann	Market Perform	Outperform	Upgrade
2018-10-26	RBC Capital	Outperform	Sector Perform	Downgrade
2018-10-26	Cantor Fitzgerald	Overweight	Overweight	Maintains
2018-10-26	Barclays	Equal-Weight	Equal-Weight	Maintains
2018-09-13	Barclays		Equal-Weight	Initiate
2018-08-20	KeyBanc	Overweight	Overweight	Maintains
2018-08-03	KeyBanc	Overweight	Overweight	Maintains
2018-08-03	Canaccord Genuity	Buy	Buy	Maintains
2018-07-25	Stifel Nicolaus	Hold	Hold	Maintains
2018-07-10	Evercore ISI Group	In-Line	Underperform	Downgrade
2018-05-24	RBC Capital	Outperform	Outperform	Maintains
2018-05-03	Stifel Nicolaus	Hold	Hold	Maintains
2018-05-03	KeyBanc	Overweight	Overweight	Maintains
2018-05-03	Canaccord Genuity	Buy	Buy	Maintains
2018-04-23	Citigroup	Neutral	Buy	Upgrade
2018-04-02	KeyBanc	Overweight	Overweight	Maintains
2018-03-13	Argus Research	Buy	Hold	Downgrade
2018-03-13	Argus	Buy	Hold	Downgrade
2018-03-08	Stifel Nicolaus	Hold	Hold	Maintains
2018-02-07	Cantor Fitzgerald	Overweight	Overweight	Maintains
2018-02-07	Baird	Outperform	Outperform	Maintains
2018-01-19	Evercore ISI Group		In-Line	Initiate
2018-01-16	SunTrust Robinson Humphrey	Buy	Hold	Downgrade
2017-11-02	RBC Capital	Top Pick	Outperform	Downgrade
2017-10-31	Baird	Neutral	Outperform	Upgrade
2017-10-27	JP Morgan	Overweight	Neutral	Downgrade
2017-10-13	Jefferies		Buy	Maintains
2017-09-19	RBC Capital		Top Pick	Initiate
2017-08-10	Morgan Stanley	Underweight	Equal-Weight	Upgrade
2017-05-02	Hilliard Lyons	Long-Term Buy	Neutral	Downgrade
2017-02-24	Citigroup	Buy	Neutral	Downgrade
2017-02-10	Oppenheimer	Outperform	Perform	Downgrade
2017-02-10	Avondale Partners	Market Outperform	Market Perform	Downgrade
2017-01-19	Barclays	Overweight	Equal-Weight	Downgrade
2017-01-06	Cantor Fitzgerald		Overweight	Initiate
2016-12-13	Morgan Stanley	Equal-Weight	Underweight	Downgrade
2016-12-01	Leerink Swann	Outperform	Market Perform	Downgrade
2016-11-07	Bank of America	Neutral	Underperform	Downgrade
2016-11-02	Baird	Outperform	Neutral	Downgrade
2016-10-06	UBS		Neutral	Initiate
2016-09-19	Bank of America		Buy	Initiate
2016-09-08	Cowen & Co.	Outperform	Market Perform	Downgrade
2016-08-03	Deutsche Bank		Buy	Maintains
2016-08-03	Citigroup		Buy	Maintains
2016-08-03	Barclays		Overweight	Maintains
2016-07-05	Raymond James	Outperform	Market Perform	Downgrade
2016-06-23	SunTrust Robinson Humphrey	Neutral	Buy	Upgrade
2016-02-23	Goldman Sachs	Buy	Neutral	Downgrade
2016-02-17	UBS		Buy	Maintains
2016-02-17	RBC Capital		Top Pick	Maintains
2016-02-17	PiperJaffray		Overweight	Maintains
2016-02-17	Oppenheimer		Outperform	Maintains
2016-02-17	Leerink Swann		Outperform	Maintains
2016-02-17	Evercore ISI Group	Buy	Hold	Downgrade
2016-02-17	Deutsche Bank		Buy	Maintains
2016-02-17	Canaccord Genuity		Buy	Maintains
2016-02-17	Barclays		Overweight	Maintains
2016-02-17	Baird		Outperform	Maintains
2016-02-17	Avondale Partners		Market Outperform	Maintains
2016-01-07	RBC Capital	Outperform	Top Pick	Upgrade
2015-11-10	Deutsche Bank		Buy	Maintains
2015-11-04	Stifel Nicolaus		Sell	Maintains
2015-11-04	Deutsche Bank		Buy	Maintains
2015-10-21	Avondale Partners		Market Outperform	Initiate
2015-10-16	Barclays		Overweight	Maintains
2015-09-29	RBC Capital	Sector Perform	Outperform	Upgrade
2015-09-16	Canaccord Genuity		Buy	Initiate
2015-09-15	Stifel Nicolaus		Sell	Maintains
2015-08-05	Stifel Nicolaus	Hold	Sell	Downgrade
2015-08-05	RBC Capital	Outperform	Sector Perform	Downgrade
2015-06-18	Oppenheimer		Outperform	Initiate
2015-04-20	SunTrust Robinson Humphrey	Buy	Neutral	Downgrade
2015-04-20	Barclays		Buy	Maintains
2015-04-07	Stifel Nicolaus		Hold	Initiate
2015-04-06	Barclays		Overweight	Maintains
2015-03-19	Baird	Neutral	Outperform	Upgrade
2015-03-09	RBC Capital		Outperform	Maintains
2015-03-03	Topeka	Buy	Hold	Downgrade
2015-02-11	Deutsche Bank		Buy	Maintains
2015-02-11	Barclays		Overweight	Maintains
2015-02-09	JP Morgan		Overweight	Maintains
2014-11-21	Cowen & Co.	Market Perform	Outperform	Upgrade
2014-10-24	Credit Suisse		Neutral	Maintains
2014-09-08	Topeka		Buy	Maintains
2014-08-06	Wells Fargo	Market Perform	Outperform	Upgrade
2014-07-25	Raymond James		Outperform	Maintains
2014-07-25	Deutsche Bank		Buy	Maintains
2014-06-27	Topeka		Buy	Initiate
2014-04-30	UBS	Neutral	Buy	Upgrade
2014-04-15	Raymond James		Outperform	Maintains
2014-03-14	SunTrust Robinson Humphrey		Buy	Initiate
2014-03-05	Barclays		Overweight	Initiate
2014-02-18	Citigroup			Initiate
2014-02-13	RBC Capital		Outperform	Initiate
2014-01-22	ISI Group	Neutral	Strong Buy	Upgrade
2013-11-20	Deutsche Bank		Buy	Initiate
2013-10-17	Stephens & Co.		Overweight	Initiate
2013-10-16	HM Global Capital		Hold	Initiate
2013-10-10	KeyBanc		Buy	Maintains
2013-09-03	Leerink Swann	Market Perform	Outperform	Upgrade
2013-08-19	Hilliard Lyons		Long-Term Buy	Initiate
2013-08-14	KeyBanc		Buy	Initiate
2013-07-26	Baird	Outperform	Neutral	Downgrade
2013-07-16	First Analysis	Overweight	Equal-Weight	Downgrade
2013-06-11	Sterne Agee		Neutral	Initiate
2013-05-31	Jefferies		Buy	Maintains
2013-04-29	Raymond James	Outperform	Market Perform	Downgrade
2013-04-26	Credit Suisse		Neutral	Maintains
2013-04-12	Jefferies		Buy	Maintains
2013-02-21	B. Riley FBR		Neutral	Initiate
2013-02-21	B. Riley		Neutral	Initiate
2013-02-06	Jefferies		Buy	Maintains
2013-02-06	Credit Suisse		Neutral	Maintains
2013-01-14	Sterne Agee		Buy	Maintains
2013-01-03	JP Morgan		Overweight	Initiate
2012-10-26	Jefferies	Hold	Buy	Upgrade
2012-10-03	Jefferies		Hold	Initiate
2012-09-04	ISI Group		Market Weight	Maintains
2012-08-17	Morgan Stanley	Overweight	Equal-Weight	Downgrade
2012-07-30	Cowen & Co.	Outperform	Neutral	Downgrade
2012-07-12	ISI Group		Market Weight	Initiate
2012-03-23	UBS		Neutral	Maintains
2012-02-28	Sterne Agee		Buy	Initiate
2012-02-23	PiperJaffray		Overweight	Maintains